Insmed | Crediti Commerciali



Trade Debtors Cambiamento Data
BioMarin Pharmaceutical USD 660.54M 117.01M 2024-12
Cytokinetics USD 16.65M 16.41M 2024-12
DBV Technologies USD 20.1M 553K 2024-09
Dynavax Technologies USD 46.91M 28.37M 2024-12
Gilead Sciences USD 4.42B 167M 2024-12
Insmed USD 52.01M 9.7M 2024-12
Novartis USD 7.56B 594M 2024-12
Regeneron Pharmaceuticals USD 6.21B 6B 2024-12
Sarepta Therapeutics USD 649.73M 133.74M 2024-12
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12



Insmed Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.